Gerald F Watts Selected Research

Gerald F Watts Research Topics

Disease

117	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 02/2002
47	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2022 - 03/2002
45	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 01/2001
44	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 01/2003
42	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2002
42	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
38	Atherosclerosis 01/2022 - 05/2002
34	Insulin Resistance 01/2017 - 02/2002
29	Obesity 07/2022 - 05/2002
28	Coronary Disease (Coronary Heart Disease) 01/2022 - 02/2003
22	Hypertension (High Blood Pressure) 07/2022 - 11/2002
20	Abdominal Obesity 04/2016 - 02/2002
17	Hypertriglyceridemia 01/2020 - 03/2006
15	Weight Loss (Weight Reduction) 11/2021 - 02/2003
15	Hypercholesterolemia 01/2021 - 03/2002
13	Inflammation (Inflammations) 01/2021 - 07/2002
12	Homozygous Familial Hypercholesterolemia 01/2020 - 08/2013
11	Chronic Renal Insufficiency 01/2022 - 09/2009
10	Myocardial Infarction 01/2022 - 03/2011
8	Pancreatitis 03/2022 - 11/2013
8	Non-alcoholic Fatty Liver Disease 01/2017 - 02/2008
7	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 02/2015
7	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 01/2013
7	Overweight 12/2018 - 01/2003
6	Acute Coronary Syndrome 01/2022 - 08/2013
6	Stroke (Strokes) 10/2021 - 10/2004
6	Hyperlipidemias (Hyperlipidemia) 11/2020 - 02/2003
5	Diabetes Mellitus 11/2022 - 08/2012
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 05/2018
5	Body Weight (Weight, Body) 08/2014 - 10/2009
4	Xanthomatosis (Xanthoma) 01/2018 - 12/2013
4	Muscular Diseases (Myopathy) 01/2018 - 02/2008
3	Vascular Calcification 11/2022 - 10/2018
3	Peripheral Arterial Disease 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

69	LDL CholesterolIBA 01/2022 - 02/2002
68	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 01/2001
64	Lipoproteins (Lipoprotein)IBA 03/2022 - 02/2002
60	LipidsIBA 11/2022 - 06/2002
58	Triglycerides (Triacylglycerol)IBA 03/2022 - 02/2002
54	oxidized low density lipoproteinIBA 01/2022 - 02/2003
52	Lipoprotein(a)IBA 07/2022 - 03/2014
42	CholesterolIBA 01/2021 - 03/2002
34	LDL Lipoproteins (beta Lipoproteins)IBA 06/2022 - 03/2002
33	HDL CholesterolIBA 01/2022 - 01/2001
29	Apolipoproteins B (ApoB)IBA 01/2020 - 03/2002
28	ApolipoproteinsIBA 11/2022 - 01/2004
25	Apolipoprotein B-100 (Apo B 100)IBA 11/2021 - 02/2002
21	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 12/2002
19	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2021 - 03/2003
17	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2022 - 11/2002
17	Fibric Acids (Fibrates)IBA 03/2022 - 01/2001
17	Insulin (Novolin)FDA Link 01/2019 - 08/2002
16	HDL LipoproteinsIBA 11/2021 - 02/2004
13	Apolipoprotein C-IIIIBA 12/2021 - 08/2002
12	LDL Receptors (LDL Receptor)IBA 07/2022 - 03/2002
12	Fish OilsIBA 11/2021 - 06/2002
11	Ezetimibe (Zetia)FDA Link 03/2022 - 05/2010
11	IsotopesIBA 11/2021 - 05/2002
11	VLDL LipoproteinsIBA 11/2021 - 01/2003
10	Apolipoprotein B-48IBA 12/2021 - 02/2003
10	Fatty Acids (Saturated Fatty Acids)IBA 10/2016 - 12/2002
10	Atorvastatin (Lipitor)FDA Link 11/2012 - 05/2002
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
9	AdiponectinIBA 09/2013 - 09/2004
8	CalciumIBA 11/2022 - 10/2018
8	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2016 - 01/2004
7	Apolipoproteins AIBA 06/2022 - 07/2005
7	Blood Glucose (Blood Sugar)IBA 12/2018 - 06/2011
7	ChylomicronsIBA 12/2016 - 02/2003
7	Apolipoprotein A-II (Apolipoprotein A2)IBA 04/2016 - 07/2006
6	Apoprotein(a) (Apolipoprotein (a))IBA 06/2022 - 12/2010
6	Proprotein Convertase 9IBA 03/2022 - 05/2016
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2018 - 05/2008
6	coenzyme Q10 (CoQ10)IBA 01/2018 - 05/2003
6	BMS201038IBA 07/2017 - 08/2013
6	C-Reactive ProteinIBA 03/2011 - 04/2002
6	Interleukin-6 (Interleukin 6)IBA 05/2010 - 06/2002
5	Antihypertensive Agents (Antihypertensives)IBA 10/2017 - 08/2012
5	Rosuvastatin Calcium (Crestor)FDA Link 06/2015 - 02/2008
5	Cholesterol Ester Transfer ProteinsIBA 09/2009 - 12/2002
4	Apolipoproteins E (ApoE)IBA 11/2022 - 11/2012
4	evolocumabIBA 01/2020 - 06/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2011
4	PCSK9 InhibitorsIBA 01/2019 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 05/2017 - 02/2004
4	Antipsychotic Agents (Antipsychotics)IBA 05/2016 - 06/2014
4	Leucine (L-Leucine)FDA Link 10/2015 - 07/2006
4	EnzymesIBA 09/2014 - 02/2004
4	mipomersenIBA 08/2014 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2017
3	CreatinineIBA 01/2022 - 06/2011
3	Uric Acid (Urate)IBA 01/2021 - 06/2011
3	LeptinIBA 01/2021 - 03/2005
3	Probucol (Lorelco)FDA Link 01/2020 - 01/2014
3	Monoclonal AntibodiesIBA 01/2019 - 12/2013

Therapy/Procedure

65	Therapeutics 01/2022 - 08/2002
13	Drug Therapy (Chemotherapy) 07/2019 - 01/2004
12	Blood Component Removal (Apheresis) 01/2020 - 08/2013
5	Secondary Prevention 02/2021 - 01/2001